Gut microbiome key in Parkinson’s, suggests study
A large metagenomics study determined that gut microbiome is at the centre of Parkinson’s disease pathogenesis.
List view / Grid view
A large metagenomics study determined that gut microbiome is at the centre of Parkinson’s disease pathogenesis.
A diabetes drug suggests a potential therapy for idiopathic pulmonary fibrosis...
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients...
Cannabidiol is being studied as a potential anticonvulsant, and it has demonstrated effectiveness in animal models of epilepsy and in humans...